An Upstream RUNX3 Enhancer, eR3 (−18m/−28h), Regulates the Development of Gut‐Associated Anti‐Tumorigenic CD8 + CD103 + Cytotoxic T Lymphocytes in Mouse and Human
Genes to Cells · 2025
DOI: 10.1111/gtc.70052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2025. Verfasst von Giselle Sek Suan Nah und 31 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Core Binding Factor Alpha 3 Subunit, T-Lymphocytes, Cytotoxic. Die Arbeit nennt 58 Literaturangaben. Gefördert von: National Medical Research Council, A*STAR (Agency for Science, Technology and Research), the National Research Foundation Singapore, the Singapore Ministry of Education under its Research Centres of Excellence initiative.
Abstract (Originalsprache)
The RUNX3 gene is frequently involved in a variety of cancers and immunological diseases. Despite such widespread association with human diseases, the transcriptional regulation of RUNX3 remains elusive. Here we report the identification of an enhancer for Runx3 , eR3(−18m/−28h) , by employing a combination of in silico prediction and in vivo verification using zebrafish and mouse models. eR3 is active in CD8 + CD103 (integrin α E ) + cytotoxic T lymphocytes (CTLs) that reside in the intestinal epithelium via their interaction with the CD103 ligand, E‐cadherin, on epithelial cells. Removal of eR3(−18m) specifically in CD8 T cells compromised the suppression of tumorigenesis in murine cancer models. In humans, single nucleotide polymorphisms (SNPs) in eR3(−28h) were overrepresented and were associated with weakened CTL activity in colorectal cancer patients. Together, our results indicate that eR3 plays a role in immune surveillance against gut‐associated tumors by upregulating RUNX3 expression in specific CTLs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
- Institute of Molecular and Cell Biology, A*STAR (Agency for Science, Technology and Research), Singapore, Singapore.
- RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
- Department of Pathology, Dunedin School of Medicine, The University of Otago, Dunedin, New Zealand.
- Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.
- Biostatistics Unit, National University of Singapore, Singapore, Singapore.
ORCID-Profile: Giselle Sek Suan Nah, Junichi Matsuo, Avinash Govind Bahirvani, King Pan Ng, Cai Ping Koh, Michelle Meng Huang Mok, Chelsia Qiuxia Wang, Vinay Tergaonker, Dominic C Voon, Md Zakir Hossain, Wei-Siang Liau, Cao Thi Ngoc Phuong, Takaomi Sanda, Judith Marsman, Julia Horsfield, Hilde Cheroutre, Yiong Huak Chan, Richie Soong, Daniel G Tenen, Yoichi Maekawa, Byrappa Venkatesh, Yoshiaki Ito, Ichiro Taniuchi, Motomi Osato
Förderung
- National Medical Research Council
- A*STAR (Agency for Science, Technology and Research)
- the National Research Foundation Singapore, the Singapore Ministry of Education under its Research Centres of Excellence initiative
- JSPS Kakenhi
- Agency for Science, Technology and Research
Zitieren
APA
Nah, G. S. S., Matsuo, J., Bahirvani, A. G., Kimura, S., Chin, D. W. L., Ng, K. P., Koh, C. P., Mok, M. M. H., Wang, C. Q., Tergaonker, V., Voon, D. C., Kohu, K., Muroi, S., Shi, J., Yu, S., Hossain, M. Z., Liau, W. S., Phuong, C. T. N., Sanda, T., …, & Osato, M. (2025). An Upstream RUNX3 Enhancer, eR3 (−18m/−28h), Regulates the Development of Gut‐Associated Anti‐Tumorigenic CD8 + CD103 + Cytotoxic T Lymphocytes in Mouse and Human. Genes to Cells. https://doi.org/10.1111/gtc.70052
Vancouver
Nah GSS, Matsuo J, Bahirvani AG, Kimura S, Chin DWL, Ng KP, et al. An Upstream RUNX3 Enhancer, eR3 (−18m/−28h), Regulates the Development of Gut‐Associated Anti‐Tumorigenic CD8 + CD103 + Cytotoxic T Lymphocytes in Mouse and Human. Genes to Cells. 2025. doi:10.1111/gtc.70052
BibTeX
@article{Nah2025,
author = {Nah, Giselle Sek Suan and Matsuo, Junichi and Bahirvani, Avinash Govind and Kimura, Shunichi and Chin, Desmond Wai Loon and Ng, King Pan and Koh, Cai Ping and Mok, Michelle Meng Huang and Wang, Chelsia Qiuxia and Tergaonker, Vinay and Voon, Dominic C and Kohu, Kazuyoshi and Muroi, Sawako and Shi, Jizhong and Yu, Shuizhou and Hossain, Md Zakir and Liau, Wei-Siang and Phuong, Cao Thi Ngoc and Sanda, Takaomi and Marsman, Judith and Horsfield, Julia and Cheroutre, Hilde and Chan, Yiong Huak and Pang, Brendan and Chong, Pei Yi and Soong, Richie and Tenen, Daniel G and Maekawa, Yoichi and Venkatesh, Byrappa and Ito, Yoshiaki and Taniuchi, Ichiro and Osato, Motomi},
title = {An Upstream RUNX3 Enhancer, eR3 (−18m/−28h), Regulates the Development of Gut‐Associated Anti‐Tumorigenic CD8 + CD103 + Cytotoxic T Lymphocytes in Mouse and Human},
journal = {Genes to Cells},
year = {2025},
doi = {10.1111/gtc.70052}
}
EUVIMED